| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0076 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.005 | 1 |